Citation
Mohd. Yunus Abd. Shukor
(2014)
Novel compound for use as medicament for treatment of hypercholesterolemia and atherosclerosis.
PI2014704025.
Abstract
The present invention provides a novel compound apigenin 5-O-a-arabinofuranosyl-8-C-b-glucopyranoside (AAG). AAG is usable for treatment or prevention of hypercholesterolemia and atherosclerosis. AAG can be isolated from an edible medicinal plant, Basella alba L. and was shown to be non toxic in cytotoxicity (in vitro), acute and sub-chronic toxicity studies (in vivo). The novel compound showed more than 80% inhibitory effect on activity of HMG-CoA reductase and able to treat hypercholesterolemia by lowering total cholesterol (TC), Low density lipoprotein (LDL) and triglyceride (TG) level in serum and significantly reduces the plaque formation in the aorta.
Download File
Full text not available from this repository.
|
Additional Metadata
| Item Type: | Patent |
|---|---|
| Application Number: | PI2014704025 |
| Filing Date: | 2014-12-28 |
| Divisions: | Faculty of Biotechnology and Biomolecular Sciences |
| Keywords: | Formulation; In vivo treatment of hypercholesterolemia and arterosclerosis |
| Depositing User: | Mohd Hafiz Che Mahasan |
| Date Deposited: | 28 Apr 2015 10:33 |
| Last Modified: | 21 Nov 2016 03:09 |
| URI: | http://psasir.upm.edu.my/id/eprint/33996 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |